TMCnet News

Global Clinical Trials Consumables Market to Grow at a CAGR of 5.8% by 2021 - Key Vendors are Eppendorf, Merck Millipore, PerkinElmer & Thermo Fisher Scientific - Research and Markets
[June 12, 2017]

Global Clinical Trials Consumables Market to Grow at a CAGR of 5.8% by 2021 - Key Vendors are Eppendorf, Merck Millipore, PerkinElmer & Thermo Fisher Scientific - Research and Markets


Research and Markets has announced the addition of the "Global Clinical Trials Consumables Market 2017-2021" report to their offering.

The global clinical trials consumables market to grow at a CAGR of 5.81% during the period 2017-2021.

The report, Global Clinical Trials Consumables Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

The latest trend gaining momentum in the market is outsourcing of drug discovery and clinical trial processes. As pharmaceutical companies become increasingly focused on R&D and drug discovery, they have commenced the outsourcing processes such as drug discoery and clinical trials on a contractual basis to research laboratories. The number of such laboratories has been rising rapidly since 2011. This trend is most likely to continue during the forecast period.



Key vendors

  • Eppendorf
  • Merck Millipore
  • PerkinElmer
  • Thermo Fisher Scientific

Other prominent vendors


  • Agilent Technologies (News - Alert)
  • Bellco Glass
  • CRYSTALGEN
  • Camlab
  • Reagecon
  • Sartorius
  • Spectrum (News - Alert) Chemical
  • VITLAB

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product type

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

PART 14: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/6z82kc/global_clinical


[ Back To TMCnet.com's Homepage ]